 | • レポートコード：GIR-105X04070 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、結腸直腸がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。結腸直腸がん治療薬の種類別市場規模（血管内皮増殖因子（VEGF）阻害剤、上皮細胞増殖因子受容体（EGFR）阻害剤、プログラム細胞死タンパク質1/PD1リガンド1（PD1/PDL1）阻害剤、BRAF・MEK阻害剤、チロシンキナーゼ（TKI）阻害剤、免疫調節剤）、用途別市場規模（放射線療法、化学療法）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・結腸直腸がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AB Science、Amgen、Array BioPharma、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Elli Lilly、Roch、Hutchison MediPharma、Merck & Co., Inc.、Mologen、Regeneron、Sanofi、Sumitomo Dainippon、Taiho Pharmaceutical、Vaccinogen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血管内皮増殖因子（VEGF）阻害剤、上皮細胞増殖因子受容体（EGFR）阻害剤、プログラム細胞死タンパク質1/PD1リガンド1（PD1/PDL1）阻害剤、BRAF・MEK阻害剤、チロシンキナーゼ（TKI）阻害剤、免疫調節剤 ・用途別分析2016年-2026年：放射線療法、化学療法 ・結腸直腸がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・結腸直腸がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・結腸直腸がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・結腸直腸がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・結腸直腸がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Colorectal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Colorectal Cancer Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Colorectal Cancer Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Colorectal Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Market segment by Application can be divided into
Radiotherapy
Chemotherapy
The key market players for global Colorectal Cancer Drugs market are listed below:
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Colorectal Cancer Drugs Introduction
1.2 Market Analysis
1.2.1 Overview: Global Colorectal Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Market Analysis
1.3.1 Overview: Global Colorectal Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Global Colorectal Cancer Drugs Market Size & Forecast
1.4.1 Global Colorectal Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Colorectal Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Colorectal Cancer Drugs Price by Type (2016-2026) & (USD/Kg)
1.5 Global Colorectal Cancer Drugs Production Capacity Analysis
1.5.1 Global Colorectal Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Colorectal Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Colorectal Cancer Drugs Market Drivers
1.6.2 Colorectal Cancer Drugs Market Restraints
1.6.3 Colorectal Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AB Science
2.1.1 AB Science Details
2.1.2 AB Science Major Business
2.1.3 AB Science Colorectal Cancer Drugs Product and Services
2.1.4 AB Science Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Colorectal Cancer Drugs Product and Services
2.2.4 Amgen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Array BioPharma
2.3.1 Array BioPharma Details
2.3.2 Array BioPharma Major Business
2.3.3 Array BioPharma Colorectal Cancer Drugs Product and Services
2.3.4 Array BioPharma Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Colorectal Cancer Drugs Product and Services
2.4.4 Bayer Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Product and Services
2.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Product and Services
2.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Elli Lilly
2.7.1 Elli Lilly Details
2.7.2 Elli Lilly Major Business
2.7.3 Elli Lilly Colorectal Cancer Drugs Product and Services
2.7.4 Elli Lilly Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Roch
2.8.1 Roch Details
2.8.2 Roch Major Business
2.8.3 Roch Colorectal Cancer Drugs Product and Services
2.8.4 Roch Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Hutchison MediPharma
2.9.1 Hutchison MediPharma Details
2.9.2 Hutchison MediPharma Major Business
2.9.3 Hutchison MediPharma Colorectal Cancer Drugs Product and Services
2.9.4 Hutchison MediPharma Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Merck & Co., Inc.
2.10.1 Merck & Co., Inc. Details
2.10.2 Merck & Co., Inc. Major Business
2.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Product and Services
2.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Mologen
2.11.1 Mologen Details
2.11.2 Mologen Major Business
2.11.3 Mologen Colorectal Cancer Drugs Product and Services
2.11.4 Mologen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Regeneron
2.12.1 Regeneron Details
2.12.2 Regeneron Major Business
2.12.3 Regeneron Colorectal Cancer Drugs Product and Services
2.12.4 Regeneron Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Colorectal Cancer Drugs Product and Services
2.13.4 Sanofi Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Sumitomo Dainippon
2.14.1 Sumitomo Dainippon Details
2.14.2 Sumitomo Dainippon Major Business
2.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Product and Services
2.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Taiho Pharmaceutical
2.15.1 Taiho Pharmaceutical Details
2.15.2 Taiho Pharmaceutical Major Business
2.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Product and Services
2.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Vaccinogen
2.16.1 Vaccinogen Details
2.16.2 Vaccinogen Major Business
2.16.3 Vaccinogen Colorectal Cancer Drugs Product and Services
2.16.4 Vaccinogen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Colorectal Cancer Drugs Sales by Manufacturer
3.1 Global Colorectal Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Colorectal Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Colorectal Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Colorectal Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Colorectal Cancer Drugs Manufacturer Market Share
3.5 Global Colorectal Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Colorectal Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Colorectal Cancer Drugs Market Size by Region
4.1.1 Global Colorectal Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Colorectal Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Colorectal Cancer Drugs Revenue (2016-2026)
4.3 Europe Colorectal Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Colorectal Cancer Drugs Revenue (2016-2026)
4.5 South America Colorectal Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Colorectal Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Colorectal Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Colorectal Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Colorectal Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Colorectal Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Colorectal Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Colorectal Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Colorectal Cancer Drugs Sales by Type (2016-2026)
7.2 North America Colorectal Cancer Drugs Sales by Application (2016-2026)
7.3 North America Colorectal Cancer Drugs Market Size by Country
7.3.1 North America Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Colorectal Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Colorectal Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Colorectal Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Colorectal Cancer Drugs Market Size by Country
8.3.1 Europe Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Colorectal Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Colorectal Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Colorectal Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Colorectal Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Colorectal Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Colorectal Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Colorectal Cancer Drugs Sales by Type (2016-2026)
10.2 South America Colorectal Cancer Drugs Sales by Application (2016-2026)
10.3 South America Colorectal Cancer Drugs Market Size by Country
10.3.1 South America Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Colorectal Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Colorectal Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Colorectal Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Colorectal Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Colorectal Cancer Drugs Typical Distributors
12.3 Colorectal Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Colorectal Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Colorectal Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. AB Science Basic Information, Manufacturing Base and Competitors
Table 4. AB Science Major Business
Table 5. AB Science Colorectal Cancer Drugs Product and Services
Table 6. AB Science Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Colorectal Cancer Drugs Product and Services
Table 10. Amgen Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 12. Array BioPharma Major Business
Table 13. Array BioPharma Colorectal Cancer Drugs Product and Services
Table 14. Array BioPharma Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Colorectal Cancer Drugs Product and Services
Table 18. Bayer Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Colorectal Cancer Drugs Product and Services
Table 22. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Colorectal Cancer Drugs Product and Services
Table 26. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Elli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Elli Lilly Major Business
Table 29. Elli Lilly Colorectal Cancer Drugs Product and Services
Table 30. Elli Lilly Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Roch Basic Information, Manufacturing Base and Competitors
Table 32. Roch Major Business
Table 33. Roch Colorectal Cancer Drugs Product and Services
Table 34. Roch Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hutchison MediPharma Basic Information, Manufacturing Base and Competitors
Table 36. Hutchison MediPharma Major Business
Table 37. Hutchison MediPharma Colorectal Cancer Drugs Product and Services
Table 38. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Merck & Co., Inc. Major Business
Table 41. Merck & Co., Inc. Colorectal Cancer Drugs Product and Services
Table 42. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Mologen Basic Information, Manufacturing Base and Competitors
Table 44. Mologen Major Business
Table 45. Mologen Colorectal Cancer Drugs Product and Services
Table 46. Mologen Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Regeneron Basic Information, Manufacturing Base and Competitors
Table 48. Regeneron Major Business
Table 49. Regeneron Colorectal Cancer Drugs Product and Services
Table 50. Regeneron Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Sanofi Basic Information, Manufacturing Base and Competitors
Table 52. Sanofi Major Business
Table 53. Sanofi Colorectal Cancer Drugs Product and Services
Table 54. Sanofi Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Sumitomo Dainippon Basic Information, Manufacturing Base and Competitors
Table 56. Sumitomo Dainippon Major Business
Table 57. Sumitomo Dainippon Colorectal Cancer Drugs Product and Services
Table 58. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Taiho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Taiho Pharmaceutical Major Business
Table 61. Taiho Pharmaceutical Colorectal Cancer Drugs Product and Services
Table 62. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Vaccinogen Basic Information, Manufacturing Base and Competitors
Table 64. Vaccinogen Major Business
Table 65. Vaccinogen Colorectal Cancer Drugs Product and Services
Table 66. Vaccinogen Colorectal Cancer Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Colorectal Cancer Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 68. Global Colorectal Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Colorectal Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Colorectal Cancer Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 71. Head Office and Colorectal Cancer Drugs Production Site of Key Manufacturer
Table 72. Global Colorectal Cancer Drugs Sales by Region (2016-2021e) & (MT)
Table 73. Global Colorectal Cancer Drugs Sales by Region (2021-2026) & (MT)
Table 74. Global Colorectal Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Colorectal Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Colorectal Cancer Drugs Sales by Type (2016-2021e) & (MT)
Table 77. Global Colorectal Cancer Drugs Sales by Type (2021-2026) & (MT)
Table 78. Global Colorectal Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Colorectal Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Colorectal Cancer Drugs Price by Type (2016-2021e) & (USD/Kg)
Table 81. Global Colorectal Cancer Drugs Price by Type (2021-2026) & (USD/Kg)
Table 82. Global Colorectal Cancer Drugs Sales by Application (2016-2021e) & (MT)
Table 83. Global Colorectal Cancer Drugs Sales by Application (2021-2026) & (MT)
Table 84. Global Colorectal Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Colorectal Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Colorectal Cancer Drugs Price by Application (2016-2021e) & (USD/Kg)
Table 87. Global Colorectal Cancer Drugs Price by Application (2021-2026) & (USD/Kg)
Table 88. North America Colorectal Cancer Drugs Sales by Country (2016-2021e) & (MT)
Table 89. North America Colorectal Cancer Drugs Sales by Country (2021-2026) & (MT)
Table 90. North America Colorectal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Colorectal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Colorectal Cancer Drugs Sales by Type (2016-2021e) & (MT)
Table 93. North America Colorectal Cancer Drugs Sales by Type (2021-2026) & (MT)
Table 94. North America Colorectal Cancer Drugs Sales by Application (2016-2021e) & (MT)
Table 95. North America Colorectal Cancer Drugs Sales by Application (2021-2026) & (MT)
Table 96. Europe Colorectal Cancer Drugs Sales by Country (2016-2021e) & (MT)
Table 97. Europe Colorectal Cancer Drugs Sales by Country (2021-2026) & (MT)
Table 98. Europe Colorectal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Colorectal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Colorectal Cancer Drugs Sales by Type (2016-2021e) & (MT)
Table 101. Europe Colorectal Cancer Drugs Sales by Type (2021-2026) & (MT)
Table 102. Europe Colorectal Cancer Drugs Sales by Application (2016-2021e) & (MT)
Table 103. Europe Colorectal Cancer Drugs Sales by Application (2021-2026) & (MT)
Table 104. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2016-2021e) & (MT)
Table 105. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2021-2026) & (MT)
Table 106. Asia-Pacific Colorectal Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Colorectal Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Colorectal Cancer Drugs Sales by Type (2016-2021e) & (MT)
Table 109. Asia-Pacific Colorectal Cancer Drugs Sales by Type (2021-2026) & (MT)
Table 110. Asia-Pacific Colorectal Cancer Drugs Sales by Application (2016-2021e) & (MT)
Table 111. Asia-Pacific Colorectal Cancer Drugs Sales by Application (2021-2026) & (MT)
Table 112. South America Colorectal Cancer Drugs Sales by Country (2016-2021e) & (MT)
Table 113. South America Colorectal Cancer Drugs Sales by Country (2021-2026) & (MT)
Table 114. South America Colorectal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Colorectal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Colorectal Cancer Drugs Sales by Type (2016-2021e) & (MT)
Table 117. South America Colorectal Cancer Drugs Sales by Type (2021-2026) & (MT)
Table 118. South America Colorectal Cancer Drugs Sales by Application (2016-2021e) & (MT)
Table 119. South America Colorectal Cancer Drugs Sales by Application (2021-2026) & (MT)
Table 120. Middle East & Africa Colorectal Cancer Drugs Sales by Country (2016-2021e) & (MT)
Table 121. Middle East & Africa Colorectal Cancer Drugs Sales by Country (2021-2026) & (MT)
Table 122. Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Colorectal Cancer Drugs Sales by Type (2016-2021e) & (MT)
Table 125. Middle East & Africa Colorectal Cancer Drugs Sales by Type (2021-2026) & (MT)
Table 126. Middle East & Africa Colorectal Cancer Drugs Sales by Application (2016-2021e) & (MT)
Table 127. Middle East & Africa Colorectal Cancer Drugs Sales by Application (2021-2026) & (MT)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Colorectal Cancer Drugs Typical Distributors
Table 131. Colorectal Cancer Drugs Typical Customers
List of Figures
Figure 1. Colorectal Cancer Drugs Picture
Figure 2. Global Colorectal Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Vascular Endothelial Growth Factor (VEGF) Inhibitors
Figure 4. Epidermal Growth Factor Receptor (EGFR) Inhibitors
Figure 5. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
Figure 6. BRAF or MEK Inhibitors
Figure 7. Tyrosine Kinase (TKI) Inhibitors
Figure 8. Immunomodulators
Figure 9. Global Colorectal Cancer Drugs Sales Market Share by Application in 2020
Figure 10. Radiotherapy
Figure 11. Chemotherapy
Figure 12. Global Colorectal Cancer Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 13. Global Colorectal Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Colorectal Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Colorectal Cancer Drugs Sales (2016-2026) & (MT)
Figure 34. Global Colorectal Cancer Drugs Production Capacity (2016-2026) & (MT)
Figure 35. Global Colorectal Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Colorectal Cancer Drugs Market Drivers
Figure 37. Colorectal Cancer Drugs Market Restraints
Figure 38. Colorectal Cancer Drugs Market Trends
Figure 39. Global Colorectal Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Colorectal Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Colorectal Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Colorectal Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Colorectal Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Colorectal Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Colorectal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Colorectal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Colorectal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Colorectal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Colorectal Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Colorectal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Colorectal Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Colorectal Cancer Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 54. Global Colorectal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Colorectal Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Colorectal Cancer Drugs Price by Application (2016-2026) & (USD/Kg)
Figure 57. North America Colorectal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Colorectal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Colorectal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Colorectal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Colorectal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Colorectal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Colorectal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Colorectal Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Colorectal Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Colorectal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Colorectal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Colorectal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Colorectal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Colorectal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Colorectal Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Colorectal Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Colorectal Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Colorectal Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
チロシンキナーゼ阻害剤の世界市場2018-2025 Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.The global tyrosine kinase inhibitors market is expanding owing to high prevalence and increase in incidence of cancer across the globe. In 2018, the global Tyrosine Kinase In…- 世界のBRAFキナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The BRAF Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- チロシンキナーゼJAK阻害剤の世界市場2018-2025 This study researches the market size of Tyrosine Kinase JAK Inhibitors, presents the global Tyrosine Kinase JAK Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of…
- 世界の未分化リンパ腫キナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The Anaplastic Lymphoma Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 腫瘍壊死因子α阻害薬の世界市場2018-2025 The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…